3RD WORLDWIDE INNOVATIVE NETWORKING (3rd WIN)
Venue: palais des congres
|Event Date/Time: Jul 06, 2011||End Date/Time: Jul 08, 2011|
|Registration Date: Jun 30, 2011|
|Early Registration Date: Nov 04, 2010|
|Abstract Submission Date: May 05, 2011|
Examples of questions for discussion and debate during WIN 3 include:
Determining the efficacy of targeted cancer therapies
Determining the efficacy of genetic and molecular biomarkers for selecting patients likely to respond to targeted therapeutics
Improved design of clinical trials with targeted therapies. Efficient comparisons. Appropriate endpoints. Combinations of therapies. Is randomization necessary?
Building more effective collaborations between academia, industry and patients
Innovation in technologies that identify genetic and molecular abnormalities in cancers Improvements in bioinformatics and applications of systems biology
We aim to create a forum for open discussion, in which your expertise and input from all stakeholders in cancer drug development are crucial. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside.